Pfizer, Actavis End Patent Fight Over Generic Lipitor
A Delaware federal judge on Tuesday dismissed pharmaceutical giant Pfizer Inc.'s patent infringement suit against Iceland-based Actavis Group HF over a generic version of anti-cholesterol drug Lipitor, after the parties announced...To view the full article, register now.
Already a subscriber? Click here to view full article